Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Life after ECMO: new study tracks recovery in cardiac arrest survivors

NCT ID NCT07031466

Knowledge-focused Sponsor: University Hospital Ostrava Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 74 people who received emergency ECMO (a heart-lung machine) after their heart stopped outside a hospital. Researchers measured their quality of life, anxiety, and depression 30 days later. The goal was to understand how well survivors recover physically and emotionally, not to test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

74 people

The number who actually took part.

Started

Jan 2022

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients who underwent eCPR at the University Hospital Ostrava

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient who underwent eCPR after OHCA at University Hospital Ostrava * Hospitalised in the period from 1. 1. 2022 to 31. 12. 2024 * Ability to undergo an interview personally or a family member able to provide information * Signed informed consent Exclusion Criteria: * Language barrier * Acute serious mental or somatic disease making the interview not feasible

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiac arrest (CA) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cardiac arrest Out-of-Hospital Cardiac Arrest postintensive care syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiac arrest (CA)

Contacts and locations

Locations

  • University Hospital Ostrava

    Ostrava, Moravian-Silesian Region, 708 52, Czechia

  • University of Ostrava

    Ostrava, Moravian-Silesian Region, 700 30, Czechia

More trials for these conditions

Other studies related to the condition(s) this trial covers.